Navigation Links
Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference
Date:2/25/2008

WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), an independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, is scheduled to present at the Canaccord Adams Small-Cap Orthopedics Conference at The Mission Bay Conference Center at UCSF, in San Francisco, CA on Tuesday, March 4, 2008 at 1:50 p.m. PT (4:50 p.m. ET).

A live Web cast of the presentation will be available on Symmetry Medical's Web site at http://www.symmetrymedical.com. Presentation slides will be posted on the Web site before the presentation begins. A replay of the Web cast will be available for 60 days after the date of the presentation.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Investors/Media: Contact:

The Ruth Group Symmetry Medical Inc.

Nick Laudico/Jason Rando Fred L. Hite

(646) 536-7030/7025 Senior Vice President

nlaudico@theruthgroup.com Chief Financial Officer

jrando@theruthgroup.com
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Symmetry Medical Reports Preliminary Fourth Quarter Revenue
2. Symmetry Medical Expands Board of Directors
3. Symmetry Medical Reports Preliminary Third Quarter Revenue
4. Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7, 2007
5. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
6. CIGNA Medical Group Selects Allscripts for Electronic Health Record
7. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
8. B-Line Medical and Immersion Medical Announce Partnership
9. MIT researcher addresses biomedical engineering challenges
10. Eklin Medical Reports Record Revenues for 2007
11. Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ILLE, Md., Nov. 30 Novav... company, announced today that the company will be...nce 2009 on December 2, 2009 at 12:30 pm local tim...provide an overview of the company,s business stra...ng milestones. A link to the live audio only pres...
(Date:11/30/2009)..., Nov. 30 Dr. Jessica Torrente, As...n University Medical Center in Washington, D.C., d...ific Gamma Imaging (BSGI) in clinical practice as ...reast cancer today at the annual meeting of the Ra..."The purpose of the exhibit was to demonstrate how...
(Date:11/30/2009)... Calif., Nov. 30 BioMari...oday that the Food and Drug Administration (FDA) h...pyridine (3,4-DAP), amifampridine phosphate, for t...c Syndrome (LEMS). 3,4-DAP has previously receive...tober 2009, the Committee for Medicinal Products f...
(Date:11/30/2009)...ON and COPENHAGEN, Nov. 30 Exiqon ... that the Harvard Medical School ICCB-Longwood Scr...MicroRNA Screening Center of Excellence. ICCB-L s...nd associated hospitals and institutions, for high...ibraries. ,, MicroRNAs are a novel class of sma...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...GO, June 2 Alternative Reproductive Resources,(AR...ether intended,parents, egg donors and surrogate m... some of the pressure from the egg donor selection...fers intended parents, for a,nominal fee, "first c...iod.,This means that participants have that window...
...ionLine adds high-end exploratory/translational me...psychopharmacology expertise; supports Kendle s...hase business, CINCINNATI, June 2 Kendle (Nasdaq...research organization (CRO), today,announced the a...ration,(DecisionLine Clinical Services), a private...
...QUAN, N.J., June 2 BioSpace, the world,s leading,...r fair company, revealed,this morning the 2008 Bio...ustry in Delaware, Maryland, Virginia and Washingt.../prnh/20080602/CLM086 ), This Hotbed Campaign fe...e biotechnology, pharmaceutical and medical device...
Other Biology Technology:ARR Offers Parents 'Extended Choice' in Egg Donor Selections 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 3Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 4Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 5BioSpace Releases the 2008 BioCapital(TM) Hotbed Campaign 2
(Date:11/30/2009)...ersity of Pittsburgh team overcame a major hurdle ...those that could lead to more efficient catalysts ...ss toxic. The researchers reported Nov. 29 in Nat...perature stability in metallic nanoparticles, the ...lnerability to extreme heat. , Gtz Veser, an ass...
(Date:11/30/2009)... The inaugural Global Conference on Systems & Ente...Washington, DC, focuses on the convergence of comp...l importance to society. , The goal of the c...vity around targeted complex systems, examined by ...ncludes Critical Infrastructure Systems, including...
(Date:11/30/2009)...ght the stress of seeing your extended family over...w research report in the December 2009 print issue...w.jleukbio.org ) shows that you might be right. He...ght lead to entirely new treatments that help keep...zema under control. That,s because researchers fro...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 1Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday Nov 7 3B Both Types of Vaccine Available for Free 60569 2Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 1Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 2Obesity Significantly Increases Side Effects of Stereotactic Body Radiation Therapy in Lung Cancer Patients 5934 3The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 1The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 2The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 3The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 4The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 5The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 6The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 7The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 8The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 9The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 10The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 11The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 12The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 13The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 14The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 15The Advisory Board Company Reports Fiscal Year 2010 Second Quarter Results 60567 16
...re resulting from dilated cardiomyopathy is rapidl...Molecular mechanisms are being studied and advance... familial forms. Intracellular [Ca2+]i homeostasis...grity, and dysregulation of [Ca2+]i is a hallmark ...r cardiac [Ca2+]i transients is calcium entry thro...
...nts with type 2 diabetes (DT2) has been elucidated... chip technologies allowing 400,000 DNA mutations ... a predisposition to DT2 have been identified. The...in-secreting cells (ZnT8), which is a potential ta...ation was carried out as a French-British-Canadian...
...e ban on smoking in Ireland resulted in an 83 perc...ent decrease in airborne carcinogens for patrons a...alth of bar workers, according to a one-year follo...ssue for April 2007 of the American Journal of Res...the American Thoracic Society. , Luke Clancy, M...
Other Biology News:Protein overexpression at heart of heart failure 2Elucidation of the genome for diabetics with DNA chips 2Elucidation of the genome for diabetics with DNA chips 3Smoking ban dramatically reduces air pollution in Irish pubs 2Smoking ban dramatically reduces air pollution in Irish pubs 3
GIBCO Dulbeccos Phosphate-Buffered Saline (D-PBS) (1X); liquid Contains calcium and magnesium from Invitrogen
Mouse Anti-JNK2 Antibody, Unconjugated from Upstate
...Immunogen: Synthetic peptide derived from the inte...ty: Specific for the internal region of the MUC5B...t band at ~590 kDa. Reactivity: Human (positive ...ry tracheobranchial epithelial cultures and deglyc...
Latex Gloves, PF- small from Santa Cruz Biotechnology, Inc.
Biology Products: